PSMA-PET guided radiation for high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether using a special PSMA-PET scan to guide radiation therapy improves treatment for men with high-risk prostate cancer that hasn't spread. You would receive standard radiation plus hormone therapy, and the scan helps the doctor target the radiation more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-risk prostate cancer that hasn't spread to lymph nodes or other organs on standard scans (CT, MRI, bone scan).
- You are able to undergo a special PET scan called PSMA-PET before starting any prostate cancer treatment.
- You are healthy enough to receive radiation to the prostate (ECOG score 0–2).
- You are willing to take hormone therapy (androgen suppression) as part of standard care.
- If you could father a child, you agree to use effective birth control during treatment and for 6 months afterward, and not donate sperm.
- You have not had prior radiation to the pelvis, prostate removal, or another cancer in the last 5 years (except certain skin cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial tests a special type of radiation therapy (SBRT) that delivers a higher dose directly to the main tumor in your prostate, guided by a PSMA PET scan. It aims to improve cancer control while limiting side effects.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This trial tests radiation therapy for men with very high-risk prostate cancer that hasn't spread. It aims to see if targeting the tumor with radiation can help control the cancer in this highest risk group.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.